[Skip to Content]
[Skip to Content Landing]
December 16, 1992

Benzodiazepine Prescription Regulations-Reply

Author Affiliations

Deputy Editor, JAMA

JAMA. 1992;268(23):3317. doi:10.1001/jama.1992.03490230046022

In Reply.  —Although Dr Sampson's descriptions of the inconvenience involved in writing triplicate prescriptions will resonate for many physicians, I wonder whether a majority of them would agree that the nuisance factor is really "the major issue for physicians." Many of his complaints could be addressed by procedural changes and would be eliminated by electronic point-of-sale prescription surveillance systems.Changes in surveillance methods could decrease the inconvenience for physicians but would not remove the need to balance concerns about confidentiality, stigma, and the freedom to prescribe appropriate treatment against attempts to control inappropriate prescriptions and diversion. These issues are carefully considered in a recent JAMA article from the National Institute on Drug Abuse.1